NxStage Medical, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 20 rows in 2008. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2008-12-16: Reporting owner Burbank Jeffrey H; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2008-10-27: Reporting owner LEWIS EARL R; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2008-08-11: Reporting owner PHILDIUS PETER P; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2008-07-23: Reporting owner ISALY SAMUEL D | ORBIMED ADVISORS LLC; Form 4; Security Director's Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2008-12-16 | Burbank Jeffrey H Director, Officer (President & CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −14,146 0 owned after | $0.34 exercise price | 2008-12-17 | |
| 2008-10-27 | LEWIS EARL R Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,166 8,166 owned after | $4.24 exercise price | 2008-10-29 | |
| 2008-08-11 | PHILDIUS PETER P Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +32,170 18,625 owned after | $0.37 exercise price | 2008-08-13 | |
| 2008-07-23 | ISALY SAMUEL D | ORBIMED ADVISORS LLC Director, 10% Owner | Director, 10% Owner | 4 | Director's Stock Option (right to buy) Derivative · Indirect · See Footnotes | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +11,667 11,667 owned after | $4.36 exercise price | 2008-08-28 | |
| 2008-07-23 | ORBIMED ADVISORS LLC | ISALY SAMUEL D Director, 10% Owner | Director, 10% Owner | 4 | Director's Stock Option (right to buy) Derivative · Indirect · See Footnotes | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +11,667 11,667 owned after | $4.36 exercise price | 2008-08-25 | |
| 2008-07-23 | ORBIMED ADVISORS LLC | ISALY SAMUEL D Director, 10% Owner | Director, 10% Owner | 4 | Director's Stock Option (right to buy) Derivative · Indirect · See Footnotes | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +11,667 11,667 owned after | $4.36 exercise price | 2008-08-12 | |
| 2008-07-23 | SILVERSTEIN JONATHAN Director, 10% Owner | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +11,667 11,667 owned after | $4.36 exercise price | 2008-07-24 | |
| 2008-05-29 | PHILDIUS PETER P Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,000 14,000 owned after | $5.39 exercise price | 2008-06-02 | |
| 2008-05-29 | Giannini Daniel A Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,000 14,000 owned after | $5.39 exercise price | 2008-06-02 | |
| 2008-05-29 | Utterberg David S Director, 10% Owner | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,000 14,000 owned after | $5.39 exercise price | 2008-06-02 | |
| 2008-05-29 | REID PERPER Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,000 14,000 owned after | $5.39 exercise price | 2008-06-02 | |
| 2008-05-29 | CHAMBON PHILIPPE Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,000 14,000 owned after | $5.39 exercise price | 2008-06-02 | |
| 2008-05-29 | MOORE CRAIG W Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,000 14,000 owned after | $5.39 exercise price | 2008-06-02 | |
| 2008-03-31 | Shea Thomas Officer (SVP Manufacturing Operations) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +150,000 150,000 owned after | $4.32 exercise price | 2008-04-02 | |
| 2008-03-27 | Webb Michael J. Officer (SVP, Quality & Regulatory) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +57,000 57,000 owned after | $4.54 exercise price | 2008-03-31 | |
| 2008-03-27 | Azel Agustin Officer (Senior VP, Manufacturing) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +57,000 57,000 owned after | $4.54 exercise price | 2008-03-31 | |
| 2008-03-27 | Turk Joseph E Jr Officer (SVP Commercial Operations) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +74,000 74,000 owned after | $4.54 exercise price | 2008-03-31 | |
| 2008-03-27 | Swan Winifred L Officer (SVP and General Counsel) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +74,000 74,000 owned after | $4.54 exercise price | 2008-03-31 | |
| 2008-03-27 | Brown Robert S. Officer (Sr. Vice President, CFO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +74,000 74,000 owned after | $4.54 exercise price | 2008-03-31 | |
| 2008-03-27 | Burbank Jeffrey H Director, Officer (President & CEO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +206,500 206,500 owned after | $4.54 exercise price | 2008-03-31 |